MediGuard
MediGuard is a private US-domiciled consumer medication monitoring service that targets healthcare providers and pharmacies in African markets, partnering with IQVIA for clinical trial referrals and the i3 Africa program for scaling support.
- Company typePrivate
- Founded2007
- HeadquartersParsippany, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What MediGuard does
MediGuard is a private, US-domiciled consumer medication monitoring service headquartered in Parsippany, with 1–10 employees and a web presence at MediGuard.org. The company describes its core technology as a healthcare platform focused on pharmacy services and clinical research, and it tags its revenue model as subscription/recurring, though no pricing, ARR, or revenue figures are publicly disclosed. Its customer segmentation is vertical, targeting healthcare providers and pharmacies with use cases in pharmacy services enhancement and clinical trial participation.
In May 2025, MediGuard was selected as one of seven startups across six African countries for the Investing in Innovation Africa (i3) program, a flagship-tier partnership intended to scale pharmacy services and healthcare access innovations through grants and strategic connections. In parallel, MediGuard operates a structured redirect integration with IQVIA's clinicalresearch.com platform (tracked via utm_source=Mediguard), suggesting a referral and clinical trial participant flow arrangement with a global clinical research leader. Its go-to-market is described as community-led, leveraging innovation program visibility and digital self-serve channels to reach SMB and individual consumer end users.
MediGuard is early-stage and operationally thin: no funding rounds, management team, patents, certifications, or product roadmap are disclosed. The strategic posture — innovation-program affiliation in Africa plus an IQVIA referral channel — points to a partnership-dependent, low-capital model rather than an independently scaled enterprise at this time.
MediGuard firmographics
Firmographics- Name
- MediGuard
- Website
- https://MediGuard.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MediGuard is a private US-domiciled consumer medication monitoring service that targets healthcare providers and pharmacies in African markets, partnering with IQVIA for clinical trial referrals and the i3 Africa program for scaling support.
- Ownership category
- akta.pro rank
MediGuard industry classification
Industry- Product category
- Consumer Medication Monitoring
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF)
- akta.pro secondary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where MediGuard is headquartered
LocationHeadquarters
- HQ city
- Parsippany
- HQ country
- United States
- HQ region
- North America
Markets served
MediGuard business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Healthcare technology services: Revenue model not publicly disclosed based on available sources.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
MediGuard product offering
Product offeringCore offering
MediGuard operates as a consumer medication monitoring service (MediGuard.org) that supports patient safety and clinical trial awareness, with current activities focused on scaling pharmacy services and healthcare access innovations across African markets through the Investing in Innovation Africa (i3) program. The platform redirects users to IQVIA's clinical research platform (clinicalresearch.com) to connect individuals with relevant clinical trials and pharmacy services.
Differentiator
Problem solved
Functional benefit
Products and services
- MediGuard Consumer Medication Monitoring Service
- Clinical Trial Referral Service
Companies that use MediGuard
Customer profileSegments1 record
Ideal customer profiles2 records
MediGuard technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MediGuard partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- IQVIAcoreMediGuard redirects users to IQVIA's clinical research platform (clinicalresearch.com), indicating a technology integration or referral partnership. The redirect URL with UTM parameters suggests a structured partnership arrangement for clinical trial participation and healthcare services.
- Investing in Innovation Africa (i3)flagshipMediGuard was selected as one of seven startups across six African countries in the i3 program. The program provides grants, strategic connections, and aims to scale impactful healthcare innovations in Africa. This suggests MediGuard is working with the program to develop and scale pharmacy services solutions.
Scale indicators1 record
Recent moves4 records
Expansion highlights4 records
MediGuard competitors and assessment
Company assessmentDirect peers
- Medisafe: Medisafe is a leading consumer digital medication adherence and monitoring platform, directly comparable to MediGuard's medication monitoring service positioning with a similar consumer-facing model.
- CareZone: CareZone is a consumer medication management and adherence platform, comparable to MediGuard's medication monitoring focus and pharmacy-services-adjacent functionality.
- AdhereTech: AdhereTech provides smart connected medication adherence monitoring solutions, directly comparable to MediGuard's consumer medication monitoring positioning.
- Antidote: Antidote is a clinical trial matching and patient recruitment platform, directly comparable to MediGuard's clinical trial referral/integration model with IQVIA.
- Mango Health: Mango Health is a consumer medication adherence and management app, directly comparable to MediGuard's consumer medication monitoring service positioning.
- mPharma: mPharma is a health tech company building pharmacy infrastructure across African markets, directly comparable to MediGuard's African pharmacy services enhancement focus.
Broad incumbents
- Babylon Health: Babylon Health is a broad digital health and telehealth platform with operations in Africa, comparable to MediGuard as a broader digital health player operating in similar African markets.
- IQVIA: IQVIA is the global leader in clinical research and healthcare data and MediGuard's existing referral partner - a broad incumbent that defines the clinical trial recruitment space MediGuard serves.
Emerging players
- TrialX: TrialX operates a clinical trial matching and patient recruitment platform, comparable to MediGuard's clinical trial participation use case and referral model.
Regional players
- Helium Health: Helium Health is an African health tech company providing EMR and healthcare operations solutions, comparable to MediGuard as a regional African health technology player in adjacent verticals.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
MediGuard social profiles
Digital presenceMediGuard financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediGuard leadership team
Management profileNumber of profiles
MediGuard funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediGuard M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediGuard
What does MediGuard do?
MediGuard operates as a consumer medication monitoring service (MediGuard.org) that supports patient safety and clinical trial awareness, with current activities focused on scaling pharmacy services and healthcare access innovations across African markets through the Investing in Innovation Africa (i3) program. The platform redirects users to IQVIA's clinical research platform (clinicalresearch.com) to connect individuals with relevant clinical trials and pharmacy services.
Is MediGuard a public or private company?
MediGuard is a private company. It is classified as unknown and is currently operating.
When was MediGuard founded?
MediGuard was founded in 2007. It employs 1 to 10 people.
Where is MediGuard based?
MediGuard is headquartered in Parsippany, United States, in the North America region.
How does MediGuard make money?
One revenue line is on record: healthcare technology services.
Who are MediGuard's main competitors?
Direct peers on record are Medisafe, CareZone, AdhereTech, Antidote, Mango Health and mPharma. Broad incumbents are Babylon Health and IQVIA. TrialX is listed as an emerging player. Helium Health is listed as a regional player.
Does MediGuard have an API?
No public API is recorded for MediGuard.
What industry is MediGuard in?
MediGuard's product category is Consumer Medication Monitoring. Its primary akta.pro industry code is HLALALAF, Telepharmacy & Prescription Fulfillment Marketplaces, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its SIC code is 7372.